Login / Signup

Phase I study of F16IL2 antibody-cytokine fusion with very low-dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation.

Christoph SchliemannTorsten KesslerAndrew F BerdelTeresa HemmerleLinus AngenendtBianca AltvaterClaudia RossigJan-Henrik MikeschGeorg LenzMichael SchäfersDario NeriMatthias StelljesWolfgang E Berdel
Published in: British journal of haematology (2021)
Keyphrases
  • stem cell transplantation
  • high dose
  • low dose
  • liver failure
  • bone marrow
  • acute myeloid leukemia
  • respiratory failure
  • dendritic cells
  • drug induced
  • aortic dissection
  • extracorporeal membrane oxygenation